EXACT Sciences (EXAS) Posts Q3 Loss of $0.03, Better Y/Y
EXACT Sciences Corp. (NASDAQ: EXAS) reports Q3 loss of $0.03, compared to ($0.11) in the same quarter last year. Revenue for the quarter was $1.3 million, versus ($663,000) million in Q08.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
